Use of PD-1 (PDCD1) inhibitors for the treatment of Richter syndrome: experience at a single academic centre

Kerry A. Rogers, Ying Huang, Emily Dotson, Jordan Lundberg, Leslie A. Andritsos, Farrukh T. Awan, Jennifer A. Woyach, John C. Byrd

Research output: Contribution to journalLetter

2 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)363-366
Number of pages4
JournalBritish Journal of Haematology
Volume185
Issue number2
DOIs
StatePublished - Apr 2019
Externally publishedYes

Fingerprint

B-Cell Chronic Lymphocytic Leukemia
Therapeutics

Keywords

  • chronic lymphocytic leukaemia
  • immune checkpoint inhibitors
  • PD-1 (PDCD1) inhibitors
  • Richter syndrome

ASJC Scopus subject areas

  • Hematology

Cite this

Use of PD-1 (PDCD1) inhibitors for the treatment of Richter syndrome : experience at a single academic centre. / Rogers, Kerry A.; Huang, Ying; Dotson, Emily; Lundberg, Jordan; Andritsos, Leslie A.; Awan, Farrukh T.; Woyach, Jennifer A.; Byrd, John C.

In: British Journal of Haematology, Vol. 185, No. 2, 04.2019, p. 363-366.

Research output: Contribution to journalLetter

Rogers, KA, Huang, Y, Dotson, E, Lundberg, J, Andritsos, LA, Awan, FT, Woyach, JA & Byrd, JC 2019, 'Use of PD-1 (PDCD1) inhibitors for the treatment of Richter syndrome: experience at a single academic centre', British Journal of Haematology, vol. 185, no. 2, pp. 363-366. https://doi.org/10.1111/bjh.15508
Rogers, Kerry A. ; Huang, Ying ; Dotson, Emily ; Lundberg, Jordan ; Andritsos, Leslie A. ; Awan, Farrukh T. ; Woyach, Jennifer A. ; Byrd, John C. / Use of PD-1 (PDCD1) inhibitors for the treatment of Richter syndrome : experience at a single academic centre. In: British Journal of Haematology. 2019 ; Vol. 185, No. 2. pp. 363-366.
@article{c320f4994eaa48ae83d5da2bd77bab76,
title = "Use of PD-1 (PDCD1) inhibitors for the treatment of Richter syndrome: experience at a single academic centre",
keywords = "chronic lymphocytic leukaemia, immune checkpoint inhibitors, PD-1 (PDCD1) inhibitors, Richter syndrome",
author = "Rogers, {Kerry A.} and Ying Huang and Emily Dotson and Jordan Lundberg and Andritsos, {Leslie A.} and Awan, {Farrukh T.} and Woyach, {Jennifer A.} and Byrd, {John C.}",
year = "2019",
month = "4",
doi = "10.1111/bjh.15508",
language = "English (US)",
volume = "185",
pages = "363--366",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Use of PD-1 (PDCD1) inhibitors for the treatment of Richter syndrome

T2 - experience at a single academic centre

AU - Rogers, Kerry A.

AU - Huang, Ying

AU - Dotson, Emily

AU - Lundberg, Jordan

AU - Andritsos, Leslie A.

AU - Awan, Farrukh T.

AU - Woyach, Jennifer A.

AU - Byrd, John C.

PY - 2019/4

Y1 - 2019/4

KW - chronic lymphocytic leukaemia

KW - immune checkpoint inhibitors

KW - PD-1 (PDCD1) inhibitors

KW - Richter syndrome

UR - http://www.scopus.com/inward/record.url?scp=85050921705&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85050921705&partnerID=8YFLogxK

U2 - 10.1111/bjh.15508

DO - 10.1111/bjh.15508

M3 - Letter

C2 - 30028000

AN - SCOPUS:85050921705

VL - 185

SP - 363

EP - 366

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

IS - 2

ER -